Aller au contenu principal
Profil bibliographique

A. S. Gazimzyanova

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
1Citations signalées
0Affiliations récentes

Les domaines associés

Cardiac Valve Diseases and TreatmentsHeart Failure Treatment and ManagementPulmonary Hypertension Research and TreatmentsCardiovascular Function and Risk FactorsCardiovascular Issues in Pregnancy

Les publications récentes

Accès ouvert 2022 article OpenAlex

Efficacy of intermittent inhaled iloprost in inoperable chronic thromboembolic pulmonary hypertension

И. Р. Гайсин, Lyubov Vladimirovna Rychkova, A. S. Gazimzyanova, Н. И. Максимов et autres

PH (pulmonary hypertension) targeted therapy may play an essential role in chronic thromboembolic pulmonary hypertension (CTEPH) patients considered inoperable. Given the limited number of PH-targeted drugs approved for CTEPH, reliable long-term data are necessary on the effects of PH-targeted drugs in patients …

ru, pk (code pays fourni par la source)

1 citation PULMONOLOGIYA
2013 conference-abstract OpenAlex

Trimetazidine may be a new additional therapy to improve symptoms and cardiac function for patients after proceeding with surgical valve replacement

И. Р. Гайсин, A. S. Gazimzyanova, Т. В. Соколова, Tatiana V Korotaeva et autres

Background: After successful surgery for valvular heart disease, symptoms and cardiac function are in general greatly improve. Nevertheless, left ventricle dysfunction and heart failure symptoms may persist and worsen postoperatively. We hypothesized that the metabolically acting agent trimetazidine would help improve symptoms …

ru (code pays fourni par la source)

0 citations European Heart Journal
2013 conference-abstract OpenAlex

Trimetazidine improves health-related quality of life in operated valvular heart disease

И. Р. Гайсин, A. S. Gazimzyanova, Albina A. Galimova, M.A. Voronova et autres

Purpose: Successful surgical intervention in valvular heart disease has been shown to prolong and improve quality of life. We aimed to evaluate postoperative health-related quality of life (HRQoL) in patients following trimetazidine therapy. Methods: 120 patients [aged 53.2±2.1 years, 60% males] 2–4 …

ru (code pays fourni par la source)

0 citations European Heart Journal

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.